Hemophilia A With Inhibitors Completed Phase 2 Trials for Coagulation factor VIIa Recombinant Human (DB00036)

Also known as: Hemophilia A With Inhibitor / Haemophilia A With Inhibitors

IndicationStatusPhase
DBCOND0032571 (Hemophilia A With Inhibitors)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03407651Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and BTreatment
NCT03196284A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With InhibitorsTreatment
NCT00951405Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With InhibitorsPrevention